Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Calhoun

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Diabetes Technology & Therapeutics|July 5, 2023
A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover TrialKlemen Dovc, Simon Bergford, Elke Fröhlich-Reiterer, et al.
Diabetes Technology & Therapeutics|July 20, 2022
Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018Rayhan A Lal, Holly Robinson, Stefanie Lanzinger, et al.
BMJ Open Diabetes Research & Care|May 10, 2024
Glucose levels measured with continuous glucose monitoring in uncomplicated pregnanciesAnders L Carlson, Roy W Beck, Zoey Li, et al.
Diabetes Technology & Therapeutics|March 18, 2025
Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension StudyRoy W Beck, Ryan J Bailey, Klara R Klein, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan PerspectiveAnastasia Albanese-O'Neill, Julia M Grimsmann, Ann-Marie Svensson, et al.
Diabetes Technology & Therapeutics|July 31, 2023
Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 DiabetesJill Weissberg-Benchell, Anthony T Vesco, Jenna Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2024
Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI StudyJorge L Jo Kamimoto, Zoey Li, Robin L Gal, et al.
Diabetes Technology & Therapeutics|November 23, 2020
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery SystemJohn W Lum, Ryan J Bailey, Victoria Barnes-Lomen, et al.
Diabetes Technology & Therapeutics|September 5, 2014
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetesH Peter Chase, Francis J Doyle, Howard Zisser, et al.
Diabetologia|February 11, 2025
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes developmentPeter Calhoun, Charles Spanbauer, Andrea K Steck, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Diabetes Technology & Therapeutics|July 5, 2023
A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover TrialKlemen Dovc, Simon Bergford, Elke Fröhlich-Reiterer, et al.
Diabetes Technology & Therapeutics|July 20, 2022
Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018Rayhan A Lal, Holly Robinson, Stefanie Lanzinger, et al.
BMJ Open Diabetes Research & Care|May 10, 2024
Glucose levels measured with continuous glucose monitoring in uncomplicated pregnanciesAnders L Carlson, Roy W Beck, Zoey Li, et al.
Diabetes Technology & Therapeutics|March 18, 2025
Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension StudyRoy W Beck, Ryan J Bailey, Klara R Klein, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan PerspectiveAnastasia Albanese-O'Neill, Julia M Grimsmann, Ann-Marie Svensson, et al.
Diabetes Technology & Therapeutics|July 31, 2023
Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 DiabetesJill Weissberg-Benchell, Anthony T Vesco, Jenna Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2024
Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI StudyJorge L Jo Kamimoto, Zoey Li, Robin L Gal, et al.
Diabetes Technology & Therapeutics|November 23, 2020
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery SystemJohn W Lum, Ryan J Bailey, Victoria Barnes-Lomen, et al.
Diabetes Technology & Therapeutics|September 5, 2014
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetesH Peter Chase, Francis J Doyle, Howard Zisser, et al.
Diabetologia|February 11, 2025
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes developmentPeter Calhoun, Charles Spanbauer, Andrea K Steck, et al.
Pageof 10